Alamar Biosciences ALMR Deferred Financing And Deferred Offering Costs Included In Accrued Liabilities
Other financials
Where this comes from
Reported directly by Alamar Biosciences in its filing.
Tagged under the XBRL concept ck0002104204:DeferredFinancingAndDeferredOfferingCostsIncludedInAccruedLiabilities.
The official record: Alamar Biosciences ’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Alamar Biosciences 's deferred financing and deferred offering costs included in accrued liabilities.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Alamar Biosciences 's deferred financing and deferred offering costs included in accrued liabilities?
- Alamar Biosciences (ALMR) reported deferred financing and deferred offering costs included in accrued liabilities of $2.09M in Q1 2026.